Prothena Corp Public (PRTA) Total Current Liabilities (2012 - 2026)
Prothena Corp Public (PRTA) recorded quarterly Total Current Liabilities of $32.5 million in Q1 2026, down 20.39% quarter-over-quarter from $40.8 million in Q4 2025, and down 32.9% on a YoY basis from $48.5 million in Q1 2025.
Prothena Corp Public (PRTA) Total Current Liabilities (2012 - 2026) Analysis & Trends
Prothena Corp Public's Total Current Liabilities history runs 15 years deep, the most recent figure standing at $32.5 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 32.9% year-over-year to $32.5 million; the TTM figure through Mar 2026 stood at $32.5 million (down 32.9% YoY), while the FY2025 annual figure was $40.8 million, down 15.79% from the prior year.
- Total Current Liabilities was $32.5 million for Q1 2026 at Prothena Corp Public, down from $40.8 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $71.6 million in Q2 2023 to a low of $32.5 million in Q1 2026.
- Historically, Total Current Liabilities has averaged $49.1 million across 5 years, with a median of $48.5 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Total Current Liabilities soared 78.44% in 2023, then sank 34.68% in 2024.
- A 5-year view of Total Current Liabilities shows it stood at $50.1 million in 2022, then increased by 13.45% to $56.9 million in 2023, then fell by 14.75% to $48.5 million in 2024, then fell by 15.79% to $40.8 million in 2025, then retreated by 20.39% to $32.5 million in 2026.
- The last three Total Current Liabilities figures came in at $32.5 million (Q1 2026), $40.8 million (Q4 2025), and $51.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 13.42 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 72.86 Mn |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - | 32.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.52 Mn |
| Dec 31, 2025 | 40.84 Mn |
| Sep 30, 2025 | 51.44 Mn |
| Jun 30, 2025 | 67.81 Mn |
| Mar 31, 2025 | 48.46 Mn |
| Dec 31, 2024 | 48.50 Mn |
| Sep 30, 2024 | 46.42 Mn |
| Jun 30, 2024 | 46.74 Mn |
| Mar 31, 2024 | 43.27 Mn |
| Dec 31, 2023 | 56.89 Mn |
| Sep 30, 2023 | 53.37 Mn |
| Jun 30, 2023 | 71.57 Mn |
| Mar 31, 2023 | 48.88 Mn |
| Dec 31, 2022 | 50.15 Mn |
| Sep 30, 2022 | 50.60 Mn |
| Jun 30, 2022 | 40.11 Mn |
| Mar 31, 2022 | 36.50 Mn |
| Dec 31, 2021 | 33.45 Mn |
| Sep 30, 2021 | 29.20 Mn |
| Jun 30, 2021 | 52.90 Mn |